Trial Profile
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Sponsors AbbVie; Allergan
- 12 Sep 2023 This trial has been completed in Poland, according to European Clinical Trials Database record.
- 22 Jun 2023 Status changed from active, no longer recruiting to completed.
- 10 Apr 2023 This trial has been completed in Denmark, according to European Clinical Trials Database record.